Biophoton therapy for chronic severe arthritis pain relief
Official title: A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
Run by First Institute of All Medicines · NCT06915012 · Data updated 2026-11-12
This study is testing if biophoton therapy can help people with chronic severe arthritis pain feel better over 12 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 102 (estimated) |
| Sponsor | First Institute of All Medicines Academic / other |
| Locations | 1 site (Butler, Pennsylvania) |
| Status | Recruiting |
| Started | March 28, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06915012 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-80 with chronic severe arthritis pain lasting at least three months and a pain rating of 5 or higher on the VAS.
✕Probably not a fit
Patients with untreated psychiatric disturbances, severe co-morbid conditions, or those relying on ventilators or having implantable electronic devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the effectiveness of biophoton therapy using Tesla BioHealing® Biophoton Generators in alleviating chronic severe pain associated with arthritis. It is a randomized, double-blinded, placebo-controlled intervention involving approximately 102 participants. The primary outcome measure is the Visual Analog Scale (VAS) for pain, while secondary measures include quality of life assessments and various psychological and sleep quality indicators. Participants will be monitored over a 12-week period to assess changes in pain and overall well-being.
Why it matters
Potential benefit: If successful, this therapy could provide significant pain relief and improve the quality of life for patients suffering from chronic severe arthritis.
How similar studies have gone: While biophoton therapy is a novel approach, similar studies in alternative pain management have shown promising results, though this specific method remains largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to give informed consent for participation in the trial. * Is able and willing to comply with all trial requirements. * Male or female aged 18-80 years old with chronic severe arthritis pain. * ≥3 months duration of chronic severe arthritis pain. * a current VAS pain rating ≥5/10. * Able to complete the treatment for the study period. * Must be fluent in English. Exclusion Criteria: * Untreated psychiatric disturbances that would affect trial participation as judged by the Caregiver or by the clinical study medical professional * Who relies on ventilators * Who had deep brain stimulators, or pacemakers, or implantable electronic devices * Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis. * Is participating in another investigational drug or device trial * Has an active infectious disease, such as COVID-19 * Pregnant women.
Where it's running
-
Tesla BioHealing Medical Center in Butler-PA
Butler, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Mariola Smotrys, MD, MBA, MSc
- Email: Mariola.Smotrys@firstallmed.org
- Phone: 302-500-3010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Ultrasound Before Corticosteroid Injection for Arthritis
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Early stratification of acute arthritis
The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.
-
Examining the effects of different exercise levels on arthritis symptoms
This study tests how different amounts of exercise can help people with arthritis feel better over six months.
-
Understanding pain in inflammatory joint diseases
This project will follow people with inflammatory joint diseases who are starting or switching biological or targeted synthetic DMARDs to try to identify different pain types and see if central sensitization and cognitive function relate to persistent pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.